AI assistant
Sending…
Sonoma Pharmaceuticals, Inc. — Director's Dealing 2007
Jan 30, 2007
35312_dirs_2007-01-30_5f8f1c76-4c46-4721-937c-7ad1c45bf5cf.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Oculus Innovative Sciences, Inc. (OCLS)
CIK: 0001367083
Period of Report: 2007-01-30
Reporting Person: French Gregory M (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2007-01-30 | Common Stock | P | 10000 | $7.8067 | Acquired | 28750 | Indirect |
More from Sonoma Pharmaceuticals, Inc.
Capital/Financing Update
2026
Apr 30
Capital/Financing Update
2026
Apr 27
Capital/Financing Update
2026
Apr 17
Regulatory Filings
2026
Apr 9
Interim / Quarterly Report
2026
Feb 10
Director's Dealing
2026
Feb 9
Board/Management Information
2026
Jan 28
Investor Presentation
2026
Jan 12
Director's Dealing
2026
Jan 2
Director's Dealing
2026
Jan 2